How a synthetic lipoprotein targets tumor metabolism to trigger cancer cell death

Northwestern Medicine scientists have developed a promising approach to killing treatment-resistant cancer cells by exploiting their hidden metabolic vulnerabilities, according to a study published in the Proceedings of the National Academy of Sciences.

Leave A Comment

Your email address will not be published. Required fields are marked *